We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 17, 2020

Effect of BMI on Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer

Breast Cancer Research


Additional Info

Breast Cancer Research
Effect of Body Mass Index on Response to Neo-Adjuvant Therapy in HER2-Positive Breast Cancer: An Exploratory Analysis of the NeoALTTO Trial
Breast Cancer Res 2020 Oct 27;[EPub Ahead of Print], S Di Cosimo, L Porcu, D Agbor-Tarh, S Cinieri, MA Franzoi, MC De Santis, C Saura, J Huober, D Fumagalli, M Izquierdo, M Piccart, MG Daidone, E de Azambuja

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading